Ilhan, Y. Et Al. 2024. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy. Expert Opinion on Pharmacotherapy , vol.25, no.11 , 1555-1563.

Ilhan, Y., Ucar, G., Baser, M. N., Guzel, H. G., Efil, S. C., Demir, B., ... ERCAN UZUNDAL, D.(2024). Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy. Expert Opinion on Pharmacotherapy , vol.25, no.11, 1555-1563.

Ilhan, Yusuf Et Al. "Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy," Expert Opinion on Pharmacotherapy , vol.25, no.11, 1555-1563, 2024

Ilhan, Yusuf Et Al. "Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy." Expert Opinion on Pharmacotherapy , vol.25, no.11, pp.1555-1563, 2024

Ilhan, Y. Et Al. (2024) . "Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy." Expert Opinion on Pharmacotherapy , vol.25, no.11, pp.1555-1563.

@article{article, author={Yusuf Ilhan Et Al. }, title={Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy}, journal={Expert Opinion on Pharmacotherapy}, year=2024, pages={1555-1563} }